Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Drug-induced hepatitis].

Terapevticheskii Arkhiv

|January 27, 2000

Summary

This summary is machine-generated.

This study identifies drugs causing hepatotoxicity and their clinical effects. Heptral effectively corrects drug-induced cholestasis and glutathione deficiency in patients with drug-induced hepatitis.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Drug-induced liver injury: diagnosis of exclusion].

Terapevticheskii arkhiv·2023

Same author

[DYSFUNCTION OF THE BILIARY TRACT: DIAGNOSIS AND TREATMENT].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2016

Same author

[Diagnosis of iron overload syndrome].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2010

Same author

[Chronic hepatitis C: etiology, pathogenesis, treatment].

Klinicheskaia meditsina·2010

Same author

[Up-to-date algorithms for diagnosis and treatment of chronic hepatitis B].

Klinicheskaia meditsina·2009

Same author

[Clinical manifestation of hepatotoxic effect of cytostatic chemicals].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2007

Area of Science:

Hepatology
Toxicology
Pharmacology

Background:

Drug-induced hepatitis (DIH) poses diagnostic and therapeutic challenges.
Accurate identification of hepatotoxic drugs and clinical presentations is crucial for patient management.

Observation:

A cohort of 62 patients diagnosed with DIH out of 2300 with hepatic lesions were analyzed.
Comprehensive biochemical tests and imaging studies were performed to assess liver function and damage.

Findings:

A direct link between drug intake and hepatitis was confirmed in all DIH patients.
Anticancer drugs caused intrahepatic cholestasis, cellular damage, and glutathione depletion.

Implications:

Early diagnosis and intervention are key for managing drug-induced liver injury.
Heptral demonstrates efficacy in treating intrahepatic cholestasis and glutathione deficiency associated with DIH.